|Articles|March 14, 2022
Early Detection of Aggregation in Biotherapeutic Formulations
Author(s)Yokogawa Fluid Imaging Technologies
Submicron Flow Imaging Microscopy with FlowCam Nano enables researchers to detect particulate sources like API aggregation and bacterial contamination that may lead to particle agglomeration if not addressed.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
3
FAQ: Shifts in FDA Regulations and Strategies in 2025
4
Charles River Incubator Cohort to Accelerate CGT Development
5
